Impacts of body weight after surgery for obstructive sleep apnea in children

W-C Hsu1, K-T Kang, W-C Weng

  • 1Department of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan. hsuwc@ntu.edu.tw

Insights

Obese children with obstructive sleep apnea (OSA) have higher residual OSA after adenotonsillectomy (T&A). Underweight children often achieve normal weight status post-surgery, improving sleep apnea outcomes.

Area of Science:

  • Pediatric Otolaryngology
  • Sleep Medicine
  • Pediatric Obesity

Background:

  • Obstructive sleep apnea (OSA) is a common condition in children.
  • Adenotonsillectomy (T&A) is a primary treatment for pediatric OSA.
  • The impact of body weight status on T&A outcomes requires further investigation.

Purpose of the Study:

  • To assess the influence of preoperative body weight status on surgical outcomes after T&A in children with OSA.
  • To evaluate changes in body weight status post-T&A in relation to OSA treatment effectiveness.

Main Methods:

  • A cohort of 161 children diagnosed with OSA via polysomnography was studied.
  • Children were categorized into four weight groups: underweight, normal, overweight, and obese based on BMI.
  • Surgical outcomes, including apnea/hypopnea index (AHI) and oxygen saturation, were compared across weight groups.

Main Results:

  • All weight groups showed significant improvements in AHI and oxygen saturation post-T&A.
  • Obese children exhibited a significantly higher incidence of residual OSA (75%) compared to other groups.
  • Over half (54%) of underweight children transitioned to normal weight status within six months post-surgery.

Conclusions:

  • While T&A improves sleep parameters for all weight statuses, obese children face a higher risk of persistent OSA.
  • Adenotonsillectomy can positively impact weight status, particularly for underweight children, leading to normal weight.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.